drugset / Trial / NCT01245101
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
RandomizedCrossoverOpen-labelTreatment
Summary
This study will examine whether intensification with raltegravir of a suppressive antiretroviral regimen in HIV infected patients with poor immune restoration has a beneficial effect on cryptic viral replication and the immune system. Specifically, the investigators will examine the effect that raltegravir intensification of ART has on episomal cDNA frequencies, immune activation, CD4+ cell counts and apoptosis, and markers of microbial translocation.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-10
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Raltegravir | Other / unclassified | 400 mg | Oral |